CybeRelease: Senate Hears On Key Policy For Biodiesel Growth

(CybeRelease, May 1, 2006) - Lake Harmony – If the United States someday replaced just 5 percent of its on-road diesel fuel with biodiesel, it would equal the amount of diesel fuel made from imported Iraqi oil annually. This was one statistic that Joe Jobe, chief executive officer of the National Biodiesel Board (NBB), shared with Congress today as he emphasized specific policy initiatives foundational to the growth of the biodiesel industry. Jobe testified before the Senate Committee on Agriculture at a hearing on the state of the biofuels industry. He highlighted the strong growth of biodiesel during the last two years. Biodiesel sales tripled from 25 million gallons in 2004 to 75 million gallons in 2005. That growth is partly spurred by rising oil costs. “As crude oil prices continue to rise, America’s trade deficit continues to balloon,” Jobe said in his testimony. “Every gallon of domestic, renewable biodiesel that is used to replace diesel fuel refined from imported crude reduces the need for imported crude and finished fuel, extends the diesel supply, and expands domestic refining capacity. Even a small reduction in demand has a positive effect on straining price pressures.”
One company linked to Biodiesel growth is Bio Solutions Manufacturing, Inc. (OTC BB: BSLM) (Frankfurt: B2T.F).

For a Free Newsletter and more information, go to www.OTCReporter.com

CybeRelease Gainers are DAG Media, Inc. (Nasdaq: DAGM), Cresud S.A.C.I.F. y A. (Nasdaq: CRESY), Industrial Services of America, Inc. (Nasdaq: IDSA), FortuNet, Inc. (Nasdaq: FNET), GigaMedia Limited (Nasdaq: GIGM), Hydrogenics Corporation (Nasdaq: HYGS), Multi-Color Corporation (Nasdaq: LABL) and Willamette Valley Vineyards, Inc. (Nasdaq: WVVI).

CybeRelease Decliners are Mechanical Technology Incorporated (Nasdaq: MKTY), PW Eagle Inc. (Nasdaq: PWEI), US LEC Corp. (Nasdaq: CLEC), WJ Communications, Inc. (Nasdaq: WJCI), Optelecom-NKF, Inc. (Nasdaq: OPTC), ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA), Aspreva Pharmaceuticals Corporation (Nasdaq: ASPV) and NeoPharm, Inc. (Nasdaq: NEOL).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $595.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail